- Advances in Health Literacy: Best Practices for Patient-centered Communication
Original Date: November 2, 2013
Presenter: Cliff Coleman, MD, MPH
The talk focuses on translating awareness and knowledge about health literacy issues into practical evidence-based patient-centered communication skills – skills which studies show are currently not practiced by most providers. A “universal precautions” approach to health communication will be emphasized. Best practices will are discussed in detail, with examples demonstrating their use. Barriers to utilizing health literacy best practices are discussed, along with strategies for overcoming such barriers.
1.5 ethics CEUs for NDs approved by OBNM
- Latent Autoimmune Diabetes of Adulthood
Original Date: November 2, 2013
Presenter: Patrick Chapman, ND
Dr. Patrick Chapman differentiates distinct features of latent autoimmune diabetes of adulthood and how they are distinguished from type-2 diabetes. He describes the pathophysiology of autoimmune diabetes and patient medical history which may suggest autoimmunity. He discusses a variety of laboratory evaluations, including continuous glucose monitoring systems (CGMS). He describes treatment with insulin and other agents, so that attendees will gain insight and comfort in prescribing both natural and pharmaceutical medications. Dr. Chapman also explains important features of patient’s lipid management in the context of this disease.
1.5 CEUs (including 0.75 pharm and 0.75 general) for NDs approved by OBNM
- Naturopathic Physiotherapy and Physiognomic Markers in Diabetes Management
Original Date: November 2, 2013
Presenter: Eric Blake, ND, LAc
Naturopathic physiotherapy (electro-hydrotherapy) treatments can be a valuable addition in NIDDM patient management. Along with dietetic treatment naturopathic physiotherapy can be useful in NIDDM for the metabolic pathology. These therapies can easily be integrated into existing clinical practice.
Naturopathic physiognomic markers of the tongue, iris, nails and skin will also be presented that can help to identify those individuals with either a genetic or metabolic tendency towards blood sugar dysregulation and NIDDM in advance of it's clinical manifestation.
1.5 general CEUs for NDs approved by OBNM
- Breakthrough Solutions for Reversing Type 2 Diabetes and Obesity On or Off a Budget
Original Date: November 2, 2013
Presenter: Dennis Godby, ND
If present trends continue, one in three children born in this century will likely develop diabetes in his or her lifetime. Obesity, equally, is on the rise, and the prevalence of both conditions is directly related to income and education. The poorest populations suffer disproportionately from diseases that can be prevented and treated using lifestyle management, dietary changes, stress management and other inexpensive, mind-body solutions. Rather than focusing on nutritional supplements, Dr. Godby will explore a breadth of proven, practical tools and techniques that clinicians can apply to their current practice. Viewers will learn how to empower patients to take control of their health using practices like blood glucose monitoring, enjoying healthy food, specific exercise techniques, emotional health awareness, fat loss methods and more.
1.5 general CEUs for NDs approved by OBNM
- Managing Diabetic Eye Disease: Integrative Medicine and Clinical Nutrition
Original Date: November 2, 2013
Presenter: James Kundart, OD
This course covers the manifestations of diabetes with regard to vision and ocular health. Emphasis is placed on diabetic retinopathy and primary open-angle glaucoma. Pharmaceutical treatment, including topical prostaglandin analogs like latanaprost and anti-VEGF (vascular endothelial growth factor) injections are included. Nutritional interventions, including those from the Age-Related Eye Disease Studies (AREDS) for age-related macular degeneration, are discussed.
1.5 CEUs (including 0.5 pharm and 1.0 general) for NDs approved by OBNM
- Pain Management of Diabetic Peripheral Neuropathy
Original Date: September 3, 2013
Presenter: Gonzalo Flores, Lac
Diabetic Neuropathy is a group of nerve disorders caused by diabetes. Diabetic peripheral neuropathy (DPN) is the leading cause of neuropathic pain. Understanding the co-morbidities of pain within multiple metabolic insults of DPN better prepares the holistic health care provider with a wider variety of therapies to utilize effective approaches for acute and preventative care.
1.5 CEUs (including 1.0 pharm and 0.5 general) for NDs approved by OBNM
- Integrative Approaches to the Management of Kidney Disease
Original Date: September 3, 2013
Presenter: Ryan Bradley, ND
This presentation provides an overview of the epidemiology, pathophysiology, diagnosis and ongoing management of chronic kidney disease (CKD) and diabetic kidney disease (DKD). Common labs required for diagnosis, emerging biomarkers and labs applied for the ongoing monitoring of patient status are discussed in detail. Special attention will be paid to dietary restrictions in these renal conditions, as well as, a discussion of lifestyle approaches to treatment and management. The indications for drug therapy and dialysis are discussed, as well as the role of natural therapeutics.
1.5 CEUs (including 0.5 pharm and 1.0 general) for NDs approved by OBNM
- Botanical Support for the Diabetic Patient
Original Date: September 14, 2013
Presenter: Yvon Rochon, PhD
Dr. Rochon explains how botanicals serve a useful role in supporting the diabetic patient, within the framework of holistic naturopathic care which emphasizes nutrition and regular exercise. Medicinal plants contain bioactive molecules that increase insulin production and sensitivity, and that regulate carbohydrate absorption and metabolism. In addition, botanicals can be used to manage the disabling or life-threatening complications of diabetes, including hypertension, elevated cholesterol and triglycerides, and organ failure.
1.5 CEUs (including 0.75 pharm and 0.75 general) for NDs approved by OBNM
- Gestational Diabetes Review and the Role of Naturopathic Medicine
Original Date: November 3, 2013
Presenter: Megan Golani, ND
Dr. Megan Golani discusses the discuss the epidemiology of gestational diabetes and its association of maternal type 2 diabetes and intrauterine exposure to diabetes being a risk factor for type 2 diabetes and metabolic syndrome in children. She explains the maternal and fetal/infant short and long term adverse outcomes associated with gestational diabetes and present strategies for preventing adverse outcomes. Dr. Golani also explains the current screening guidelines and treatment approaches of gestational diabetes including medication management of metformin vs. insulin.
1.5 CEUs (including 0.25 pharm and 1.25 general) for NDs approved by OBNM
